>
pdufa.bio

LCAR-B38M CAR-T

Updated ยทnext FDA decision on the calendar

LCAR-B38M CAR-T is a Legend Biotech Corp program. Its next catalyst is a Readout in Dec 2027. Every date links its source.

LEGN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Legend Biotech Corp (LEGN). We track 2 catalyst events for this program: 1 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2026LEGNReadout · Dec 2027LEGN

Questions

When is LCAR-B38M CAR-T's next FDA decision or readout?

The next tracked catalyst for LCAR-B38M CAR-T is a Readout in Dec 2027.

What happened at LCAR-B38M CAR-T's most recent FDA decision?

No FDA decision for LCAR-B38M CAR-T is in our archive yet.

Who makes LCAR-B38M CAR-T?

Legend Biotech Corp (LEGN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.